SARM1 becomes activated when the respective NMNAT is disrupted by mutation or (for NMNAT2) by axonal transport deficiency, underlying involvement of the pathway in LCA9 and glaucoma models respectively. This evidence concerns the gene NMNAT2 and glaucoma.